Drug manufacturers are reporting positive strides in terms of increasing access to investigational drugs outside clinical trials, according to a Government Accounting Office (GAO) report issued Monday (September 9). Of […]
More than four years and hundreds of clinical trials later, Eli Lilly’s Nicole Sheetz is an even bigger believer than before in the power of electronic trial master files (eTMFs) […]
The Association of Clinical Research Professionals (ACRP) welcomes The Medical University of South Carolina (MUSC) as the latest member of the ‘Workforce Innovation Steering Committee’ (WISC). The WISC is a […]
In a dramatic upsurge since the 1980s, cancer drugs now account for more than one-fourth of all new drug approvals in the United States since 2010, up from 4% a […]
With the clear understanding that using a placebo in randomized controlled clinical trials of therapies to treat hematologic malignancy and oncologic disease for which there is known effective therapy is […]